Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 13 Mar 2023
Intravenous (IV) ketamine is effective in adults resistant to depression. The response was similar to that seen in younger patients, two new studies show.
Read Full NewsHere's some of what is coming soon to NeurologyLive® this week.
Continuem's PIPE-307 trial for relapsing-remitting multiple sclerosis failed to meet primary goals, yet the company remains committed to exploring future therapies.
Gain Therapeutics advances Parkinson's treatment with GT 2287, showcasing promising safety and tolerability in ongoing trials. Discover the latest findings.
Daily Lemon Water Lowers Serum Urate Levels in Patients With Hyperuricemia
COPD in 2025: Year in Review
FDA Approves FUROSCIX On-Body Injector for Pediatric Patients, Accepts sNDA for ReadyFlow Autoinjector
Nephrology in 2025: Year in Review
1.
Study reveals that older women frequently receive an incorrect breast cancer diagnosis.
2.
New policy review highlights the importance of health-related quality of life in advanced cancer
3.
World's premier cancer institute faces crippling cuts and chaos
4.
Key mechanism behind prostate cancer drug resistance reveals potential new treatment strategy
5.
Top Cancer Centers; Phase III Win in Prostate Cancer; Screening Recs for Anal Cancer
1.
Optimizing the Diagnosis and Treatment of Hematological Diseases Through Artificial Intelligence
2.
AI Meets the Gut Microbiome: Early Detection of GI Malignancies Redefined
3.
Immunotherapy Breakthroughs: Transforming Cancer Care Across All Oncology Fields
4.
Effective Management Strategies for Sickle Cell Crisis: Insights from Medical Experts
5.
CAR T-Cell Therapy: Revolutionizing Hematologic Malignancies
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Complexities of Ph Negative ALL - Part V
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
CDK4/6 Inhibitors Redefining Treatment for HR+/HER2- aBC In Post-Menopausal Women- A Panel Discussion
4.
Updates on Standard V/S High Risk Myeloma Treatment
5.
Navigating the Complexities of Ph Negative ALL - Part VI
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge